Selected research
Market Outlook & Growth Opportunities
Global Veterinary API Manufacturing Market Outlook and Growth Opportunities 2026
Market perspective
The global Veterinary API Manufacturing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Veterinary API Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Veterinary API Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Veterinary API Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Veterinary API Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Veterinary API Manufacturing market include Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Jiangsu Lingyun Pharmaceutical Co., Ltd., SUANFARMA, Ofichem Group, NGL Fine-Chem Ltd., Menadiona, FIS - Fabbrica Italiana Sintetici S.p.A, Excel Industries Ltd. and Alivira Animal Health Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Veterinary API Manufacturing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Veterinary API Manufacturing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Veterinary API Manufacturing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Veterinary API Manufacturing market.
Veterinary API Manufacturing Segment by Company
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
Jiangsu Lingyun Pharmaceutical Co., Ltd.
SUANFARMA
Ofichem Group
NGL Fine-Chem Ltd.
Menadiona
FIS - Fabbrica Italiana Sintetici S.p.A
Excel Industries Ltd.
Alivira Animal Health Ltd.
Afton Pharma
Veterinary API Manufacturing Segment by Type
NSAIDs
Anti-infectives
Antiparasitic
Biologics
Vaccines
Others
Veterinary API Manufacturing Segment by Application
In House
Contract Outsourcing
Veterinary API Manufacturing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Veterinary API Manufacturing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Veterinary API Manufacturing key companies, revenue, market share, and recent developments.
3. To split the Veterinary API Manufacturing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Veterinary API Manufacturing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Veterinary API Manufacturing significant trends, drivers, influence factors in global and regions.
6. To analyze Veterinary API Manufacturing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary API Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary API Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary API Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary API Manufacturing industry.
Chapter 3: Detailed analysis of Veterinary API Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Veterinary API Manufacturing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Veterinary API Manufacturing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- NSAIDs
- Anti-infectives
- Antiparasitic
- Biologics
- Vaccines
- Others
Applications
- In House
- Contract Outsourcing
Companies covered
- Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
- Jiangsu Lingyun Pharmaceutical Co., Ltd.
- SUANFARMA
- Ofichem Group
- NGL Fine-Chem Ltd.
- Menadiona
- FIS - Fabbrica Italiana Sintetici S.p.A
- Excel Industries Ltd.
- Alivira Animal Health Ltd.
- Afton Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Veterinary API Manufacturing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Veterinary API Manufacturing Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Veterinary API Manufacturing Market Dynamics
- 2.1 Veterinary API Manufacturing Industry Trends
- 2.2 Veterinary API Manufacturing Industry Drivers
- 2.3 Veterinary API Manufacturing Industry Opportunities and Challenges
- 2.4 Veterinary API Manufacturing Industry Restraints
3 Veterinary API Manufacturing Market by Company
- 3.1 Global Veterinary API Manufacturing Company Revenue Ranking in 2025
- 3.2 Global Veterinary API Manufacturing Revenue by Company (2021-2026)
- 3.3 Global Veterinary API Manufacturing Company Ranking (2024-2026)
- 3.4 Global Veterinary API Manufacturing Company Manufacturing Base and Headquarters
- 3.5 Global Veterinary API Manufacturing Company Product Type and Application
- 3.6 Global Veterinary API Manufacturing Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Veterinary API Manufacturing Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Veterinary API Manufacturing Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Veterinary API Manufacturing Market by Type
- 4.1 Veterinary API Manufacturing Type Introduction
- 4.1.1 NSAIDs
- 4.1.2 Anti-infectives
- 4.1.3 Antiparasitic
- 4.1.4 Biologics
- 4.1.5 Vaccines
- 4.1.6 Others
- 4.2 Global Veterinary API Manufacturing Sales Value by Type
- 4.2.1 Global Veterinary API Manufacturing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Veterinary API Manufacturing Sales Value by Type (2021-2032)
- 4.2.3 Global Veterinary API Manufacturing Sales Value Share by Type (2021-2032)
5 Veterinary API Manufacturing Market by Application
- 5.1 Veterinary API Manufacturing Application Introduction
- 5.1.1 In House
- 5.1.2 Contract Outsourcing
- 5.2 Global Veterinary API Manufacturing Sales Value by Application
- 5.2.1 Global Veterinary API Manufacturing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Veterinary API Manufacturing Sales Value by Application (2021-2032)
- 5.2.3 Global Veterinary API Manufacturing Sales Value Share by Application (2021-2032)
6 Veterinary API Manufacturing Regional Value Analysis
- 6.1 Global Veterinary API Manufacturing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Veterinary API Manufacturing Sales Value by Region (2021-2032)
- 6.2.1 Global Veterinary API Manufacturing Sales Value by Region: 2021-2026
- 6.2.2 Global Veterinary API Manufacturing Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Veterinary API Manufacturing Sales Value (2021-2032)
- 6.3.2 North America Veterinary API Manufacturing Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Veterinary API Manufacturing Sales Value (2021-2032)
- 6.4.2 Europe Veterinary API Manufacturing Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Veterinary API Manufacturing Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Veterinary API Manufacturing Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Veterinary API Manufacturing Sales Value (2021-2032)
- 6.6.2 South America Veterinary API Manufacturing Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Veterinary API Manufacturing Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Veterinary API Manufacturing Sales Value Share by Country, 2025 VS 2032
7 Veterinary API Manufacturing Country-level Value Analysis
- 7.1 Global Veterinary API Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Veterinary API Manufacturing Sales Value by Country (2021-2032)
- 7.2.1 Global Veterinary API Manufacturing Sales Value by Country (2021-2026)
- 7.2.2 Global Veterinary API Manufacturing Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.7.2 France Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.14.2 China Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.17.2 India Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
- 8.1.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Company Information
- 8.1.2 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Business Overview
- 8.1.3 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 8.1.4 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Product Portfolio
- 8.1.5 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Recent Developments
- 8.2 Jiangsu Lingyun Pharmaceutical Co., Ltd.
- 8.2.1 Jiangsu Lingyun Pharmaceutical Co., Ltd. Company Information
- 8.2.2 Jiangsu Lingyun Pharmaceutical Co., Ltd. Business Overview
- 8.2.3 Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 8.2.4 Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Product Portfolio
- 8.2.5 Jiangsu Lingyun Pharmaceutical Co., Ltd. Recent Developments
- 8.3 SUANFARMA
- 8.3.1 SUANFARMA Company Information
- 8.3.2 SUANFARMA Business Overview
- 8.3.3 SUANFARMA Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 8.3.4 SUANFARMA Veterinary API Manufacturing Product Portfolio
- 8.3.5 SUANFARMA Recent Developments
- 8.4 Ofichem Group
- 8.4.1 Ofichem Group Company Information
- 8.4.2 Ofichem Group Business Overview
- 8.4.3 Ofichem Group Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 8.4.4 Ofichem Group Veterinary API Manufacturing Product Portfolio
- 8.4.5 Ofichem Group Recent Developments
- 8.5 NGL Fine-Chem Ltd.
- 8.5.1 NGL Fine-Chem Ltd. Company Information
- 8.5.2 NGL Fine-Chem Ltd. Business Overview
- 8.5.3 NGL Fine-Chem Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 8.5.4 NGL Fine-Chem Ltd. Veterinary API Manufacturing Product Portfolio
- 8.5.5 NGL Fine-Chem Ltd. Recent Developments
- 8.6 Menadiona
- 8.6.1 Menadiona Company Information
- 8.6.2 Menadiona Business Overview
- 8.6.3 Menadiona Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 8.6.4 Menadiona Veterinary API Manufacturing Product Portfolio
- 8.6.5 Menadiona Recent Developments
- 8.7 FIS - Fabbrica Italiana Sintetici S.p.A
- 8.7.1 FIS - Fabbrica Italiana Sintetici S.p.A Company Information
- 8.7.2 FIS - Fabbrica Italiana Sintetici S.p.A Business Overview
- 8.7.3 FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 8.7.4 FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Product Portfolio
- 8.7.5 FIS - Fabbrica Italiana Sintetici S.p.A Recent Developments
- 8.8 Excel Industries Ltd.
- 8.8.1 Excel Industries Ltd. Company Information
- 8.8.2 Excel Industries Ltd. Business Overview
- 8.8.3 Excel Industries Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 8.8.4 Excel Industries Ltd. Veterinary API Manufacturing Product Portfolio
- 8.8.5 Excel Industries Ltd. Recent Developments
- 8.9 Alivira Animal Health Ltd.
- 8.9.1 Alivira Animal Health Ltd. Company Information
- 8.9.2 Alivira Animal Health Ltd. Business Overview
- 8.9.3 Alivira Animal Health Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 8.9.4 Alivira Animal Health Ltd. Veterinary API Manufacturing Product Portfolio
- 8.9.5 Alivira Animal Health Ltd. Recent Developments
- 8.10 Afton Pharma
- 8.10.1 Afton Pharma Company Information
- 8.10.2 Afton Pharma Business Overview
- 8.10.3 Afton Pharma Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 8.10.4 Afton Pharma Veterinary API Manufacturing Product Portfolio
- 8.10.5 Afton Pharma Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst